Ovarian Cancer - Pipeline Review, H2 2015

Ovarian Cancer - Pipeline Review, H2 2015

Code: GMDHC7416IDB | Published: Dec-2015 | Pages: 1698 | Global Markets Direct
Price :

* Required Fields



Ovarian Cancer - Pipeline Review, H2 2015


Global Markets Directs, Ovarian Cancer - Pipeline Review, H2 2015, provides an overview of the Ovarian Cancers therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Ovarian Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ovarian Cancer and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

3-V Biosciences, Inc.
A. Menarini Industrie Farmaceutiche Riunite Srl
AB Science SA
AbbVie Inc.
Abeona Therapeutics, Inc.
AbGenomics International, Inc.
Acetylon Pharmaceuticals, Inc.
Adaptimmune Limited
Aduro BioTech, Inc.
Advanced Accelerator Applications SA
Advantagene, Inc.
Advaxis, Inc.
Advenchen Laboratories, LLC
Aeterna Zentaris Inc.
Agilvax, Inc.
Alchemia Limited
Alethia Biotherapeutics Inc.
Almac Discovery Limited
Ambrx, Inc.
Amgen Inc.
Anavex Life Sciences Corp.
ANP Technologies, Inc.
Antoxis Limited
Aphios Corporation
Aposense Ltd.
Aprea AB
Armour Therapeutics Inc.
Arog Pharmaceuticals, Inc.
ArQule, Inc.
Array BioPharma Inc.
Arrien Pharmaceuticals, LLC
Ascenta Therapeutics, Inc.
Astellas Pharma Inc.
Astex Pharmaceuticals, Inc.
AstraZeneca Plc
Atara Biotherapeutics, Inc.
AVAX Technologies, Inc.
AVEO Pharmaceuticals, Inc.
Avipep Pty Ltd
Azaya Therapeutics, Inc.
Basilea Pharmaceutica AG
Bavarian Nordic A/S
Bayer AG
BeiGene(Beijing) Co.,Ltd
Beth Israel Deaconess Medical Center, Inc.
BioAtla, LLC
BioCancell Ltd
BioMoti Limited
Bionomics Limited
BioNumerik Pharmaceuticals, Inc.
Bioo Therapeutics
Biscayne Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
Boston Biomedical, Inc.
Bristol-Myers Squibb Company
Caladrius Biosciences, Inc.
Calithera Biosciences, Inc.
CASI Pharmaceuticals Inc.
Cavion LLC
cCAM Biotherapeutics Ltd.
Cellceutix Corporation
Celldex Therapeutics, Inc.
Cellectar Biosciences, Inc.
Cellular Biomedicine Group, Inc.
Celon Pharma Sp. z o.o.
Celsion Corporation
Celyad SA
Ceronco Biosciences
Cerulean Pharma, Inc.
Chikujee Therapeutics
Chipscreen Biosciences Ltd
Clevexel Pharma SAS
Clovis Oncology, Inc.
CohBar, Inc.
Commence Bio, Inc.
Compliment Corporation
Critical Outcome Technologies Inc.
CritiTech, Inc.
CTI BioPharma Corp.
Cyclacel Pharmaceuticals, Inc.
CytRx Corporation
CZ BioMed Corp
Daiichi Sankyo Company, Limited
Deciphera Pharmaceuticals, LLC
Dr. Reddys Laboratories Limited
EirGenix Inc.
Eisai Co., Ltd.
Eli Lilly and Company
Endocyte, Inc.
EntreChem, S.L.
Epirus Biopharmaceuticals, Inc.
Esperance Pharmaceuticals, Inc.
Exelixis, Inc.
F. Hoffmann-La Roche Ltd.
Fortress Biotech, Inc.
Fujifilm Corporation
Galena Biopharma, Inc.
Galileo Research s.r.l.
GamaMabs Pharma S.A.
Ganymed Pharmaceuticals AG
Genentech, Inc.
Generex Biotechnology Corporation
Genmab A/S
Genor BioPharma Co., Ltd.
GlaxoSmithKline Plc
Glenmark Pharmaceuticals Ltd.
GlycoNex Inc.
Glycotope GmbH
GP Pharm, S.A.
Gradalis Inc.
Halozyme Therapeutics, Inc.
Heat Biologics, Inc.
HEC Pharm Co., Ltd.
Hemispherx Biopharma, Inc.
Horizon Pharma Plc
Huabo Biopharm Co., Ltd.
Ignyta, Inc.
Ildong Pharmaceutical Co., Ltd.
Immune Design Corp.
ImmunoFrontier, Inc.
ImmunoGen, Inc.
Immunomedics, Inc.
Immunovaccine, Inc.
Incyte Corporation
Inflection Biosciences Limited
Innate Immunotherapeutics Ltd
Innate Pharma SA
INSYS Therapeutics, Inc.
Inventiva SAS
Jiangsu Kanion Pharmaceutical Co., Ltd.
Johnson & Johnson
Juno Therapeutics Inc.
Karyopharm Therapeutics, Inc.
Komipharm International Co., Ltd.
Kyowa Hakko Kirin Co., Ltd.
Laboratoire HRA Pharma
Lees Pharmaceutical Holdings Limited
LegoChem Biosciences, Inc
Lipocure Ltd.
Lymphocyte Activation Technologies, S.A.
Mabion SA
MabVax Therapeutics Holdings, Inc.
MacroGenics, Inc.
Mebiopharm Co., Ltd.
Medestea Research & Production S.p.A.
MediaPharma s.r.l.
MedImmune, LLC
Medivation, Inc.
MEI Pharma, Inc.
Merck & Co., Inc.
Merck KGaA
Merrimack Pharmaceuticals, Inc.
Merus B.V.
Millennium Pharmaceuticals, Inc.
MolMed S.p.A.
Momenta Pharmaceuticals, Inc.
Monopar Therapeutics LLC
Morphotek, Inc.
Mundipharma International Ltd
Mycenax Biotech Inc.
Natco Pharma Limited
Nektar Therapeutics
Nemucore Medical Innovations, Inc.
Neovacs SA
Nerviano Medical Sciences S.r.l.
Neurimmune Holding AG
Northwest Biotherapeutics, Inc.
Novartis AG
NuCana BioMed Limited
Oasmia Pharmaceutical AB
OBI Pharma, Inc.
Omeros Corporation
Omnitura Therapeutics Inc.
OncBioMune Pharmaceuticals Inc.
Oncobiologics, Inc.
Oncodesign SA
OncoHoldings, Inc.
Oncolix, Inc.
Oncology Research International Limited
Oncolytics Biotech Inc.
OncoMed Pharmaceuticals, Inc.
Oncothyreon Inc.
Ono Pharmaceutical Co., Ltd.
Onyx Pharmaceuticals, Inc.
Optimum Therapeutics, LLC
ORCA Therapeutics B.V.
OSE Pharma SA
Otsuka Holdings Co., Ltd.
Oxford BioMedica Plc
Panacela Labs, Inc.
PDS Biotechnology Corporation
PEP-Therapy SAS
Pfizer Inc.
Pharma Mar, S.A.
Pharmacyclics, Inc.
Pharmicell Co., Ltd.
Polaris Pharmaceuticals, Inc.
Polyplus-Transfection SA
Pono Pharma
Precision Biologics, Inc.
Prima BioMed Ltd.
PsiOxus Therapeutics Limited
Puma Biotechnology, Inc.
Qu Biologics Inc.
Quantum Pharmaceuticals
Quest PharmaTech Inc.
Recepta Biopharma S.A.
Rexahn Pharmaceuticals, Inc.
Rigontec GmbH
Rosetta Genomics, Ltd.
Samyang Holdings Corporation
Sanofi Pasteur SA
Scancell Holdings Plc
Sellas Inc.
Serina Therapeutics, Inc.
Shenzen SiBiono GeneTech Co., Ltd
Sigma-Tau S.p.A.
Soricimed Biopharma Inc.
Sorrento Therapeutics, Inc.
Sotio a.s.
Spectrum Pharmaceuticals, Inc.
Sphaera Pharma Pvt. Ltd.
Starpharma Holdings Limited
Sumitomo Dainippon Pharma Co., Ltd.
Sun Pharma Advanced Research Company Ltd.
Supratek Pharma Inc.
Susavion Biosciences, Inc.
Synta Pharmaceuticals Corp.
Takeda Pharmaceutical Company Limited
Takis S.r.l.
TapImmune Inc.
Tara Immuno-Oncology Therapeutics LLC
Targovax AS
Tesaro, Inc.
TetraLogic Pharmaceuticals
Theravectys SA
TVAX Biomedical, Inc.
TyrNovo Ltd.
Tyrogenex, Inc.
ValiRx Plc
Vascular Biogenics Ltd.
VentiRx Pharmaceuticals, Inc.
Verastem, Inc.
VG Life Sciences, Inc.
VioQuest Pharmaceuticals, Inc.
ViraTherapeutics GmbH
Viventia Bio Inc.
Welichem Biotech Inc.
Zensun (Shanghai) Sci & Tech Co., Ltd

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]

2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal

3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.


There are no reports matching the selection.

Browse similar reports by category:
Pharmaceuticals & Healthcare
Global Markets Direct

Our Clients